Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

Clinical trial NCT02016833 · COMPLETED

Trial details

NCT number: NCT02016833
Sponsor: PX Biosolutions
Status: COMPLETED
Study type: OBSERVATIONAL

Ovarian Serous Adenocarcinoma Undifferentiated Carcinoma of Ovary Cervical Cancer Cervical Intraepithelial Neoplasia, Grade 3 Acute Myeloid Leukemia Chronic Myeloid Leukemia

Start date: 2013-10-01
Primary completion: 2014-06-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.